Alda DS Chewable Tablet
Tablet
Eskayef Pharmaceuticals Ltd.Generic:
Alogliptin BenzoateWeight:
12.5 mgbest Price:
৳ 12.00Generic
Alogliptin Benzoate
Contraindications
Common side effects are nasopharyngitis, headache and upper respiratory tract infection.
Side Effects
Pregnancy Category B. No adequate or well-controlled studies in pregnant women have been conducted with Alogliptin. Alogliptin tablets should be used during pregnancy only if clearly needed. It is not known whether Alogliptintin is excreted in human milk. caution should be exercised when Alogliptin is administered to a nursing woman.
Pregnancy And Lactation
Acute pancreatitis: If pancreatitis is suspected, promptly Alogliptin should be discontinued. Hypersensitivity: There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Alogliptin such as anaphylaxis, angioedema and severe cutaneous adverse reactions. In such cases, promptly Alogliptin should be discontinued. Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality can not be excluded. If liver injury is detected, promptly interrupt Alogliptin and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Alogliptin if liver injury is confirmed and no alternative etiology can be found. Hypoglycemia: When an insulin secretagogue (e.g. sulfonylurea) or insulin is used in combination with Alogliptin, a lower dose of the insulin secretagogue or insulin may be required to minimize the risk of hypoglycaemia. Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Alogliptin or any other antidiabetic drug.
Therapeutic
Dipeptidyl Peptidase-4 (DPP-4) inhibitor
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Over The Counter Products
